Categories /
Subscribe to Closing Arguments
Sign up for new weekly newsletter Closing Arguments to get the latest about ongoing trials, major litigation and hot cases and rulings in courthouses around the U.S. and the world.
In this Wednesday, April 8, 2020 photo provided by the Center for Pharmaceutical Research, a participant in a COVID-19 coronavirus vaccine trial receives an injection in Kansas City, Mo. This early safety study, called a Phase 1 trial, is using a vaccine candidate developed by Inovio Pharmaceuticals. (Center for Pharmaceutical Research via AP)
Sign up for new weekly newsletter Closing Arguments to get the latest about ongoing trials, major litigation and hot cases and rulings in courthouses around the U.S. and the world.